Chair(s): Marieke L. Duiverman, Antoine Froidure, Catharina C. Moor
Session type: Hot topics
Marlies S. Wijsenbeek
Session content
Christopher Ryerson
Replay
Slides
Michael Kreuter
Replay
Slides
Are steroids still the first-line therapy for pulmonary sarcoidosis?
Marlies S. Wijsenbeek
Replay
Slides
Elisabetta Renzoni
Replay
Slides
Replay
Session aims
to discuss the most important controversies in the field of ILDs in order to improve future ILD management, for example: i) what is the most suitable therapy for sarcoidosis and is the treatment of fibrosing ILDs following a similar path to that of other diseases, such as pulmonary hypertension with combination therapies?; ii) significant controversy is the latest classification of interstitial pneumonia, which must be critically discussed, also with regard to the practical implementation of this recommendation